| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.84B | 40.74B | 38.47B | 35.07B | 31.50B | 28.82B |
| Gross Profit | 27.91B | 27.19B | 26.14B | 23.94B | 21.79B | 20.04B |
| EBITDA | 6.81B | 8.32B | 6.43B | 5.43B | 7.02B | 3.93B |
| Net Income | 5.22B | 5.23B | 3.87B | 3.20B | 3.00B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 62.46B | 63.27B | 63.88B | 62.50B | 59.11B | 57.17B |
| Cash, Cash Equivalents and Short-Term Investments | 35.66B | 34.92B | 35.15B | 35.21B | 33.89B | 28.39B |
| Total Debt | 247.90M | 115.78M | 98.50M | 112.35M | 71.73M | 61.66M |
| Total Liabilities | 23.22B | 23.33B | 22.86B | 21.14B | 20.49B | 18.33B |
| Stockholders Equity | 39.25B | 39.95B | 40.45B | 40.88B | 38.24B | 38.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.58B | 4.22B | 2.02B | 530.04M | 2.05B |
| Operating Cash Flow | 0.00 | 4.86B | 4.88B | 2.88B | 1.25B | 2.66B |
| Investing Cash Flow | 0.00 | 1.08B | -1.64B | -747.37M | 4.70B | -1.17B |
| Financing Cash Flow | 0.00 | -5.96B | -5.22B | -1.02B | -765.90M | -749.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥69.78B | 12.38 | 13.96% | 2.16% | 10.89% | -4.99% | |
78 Outperform | ¥48.79B | 12.84 | 8.02% | 2.73% | 8.26% | 9.09% | |
77 Outperform | ¥74.86B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
72 Outperform | ¥99.38B | 18.71 | ― | 2.03% | 3.64% | 51.48% | |
72 Outperform | ¥50.64B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | ¥4.49B | -18.61 | ― | ― | -40.57% | 83.14% |